Chronic type B hepatitis and the "healthy" HBsAg carrier state.
about
Tiopronin for chronic hepatitis BDeterminants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearance.Hepatitis B virus biology.Intrahepatic T cells in hepatitis B: viral control versus liver cell injury.Sexually transmitted hepatitis: a review.New animal models of hepatitis B and C.Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic miceCurrent status of antiviral therapy for hepatitis BTherapeutic management of hepatitis B-related cirrhosis.Improving health Professional's knowledge of hepatitis B using cartoon based learning tools: a retrospective analysis of pre and post testsToo much of a good thing? When to stop catch-up vaccinationHepatitis B virus infection and primary hepatocellular carcinoma.Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in MiceHepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.High-level hepatitis B virus replication in transgenic mice.Universal emergence of precore mutant hepatitis B virus along with seroconversion to anti-HBe irrespective of subsequent activity of chronic hepatitis B.The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infectionThe carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liverAntibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.Recommendations and potential future options in the treatment of hepatitis B.Relevance of cysteine residues for biosynthesis and antigenicity of human hepatitis B virus e protein.Revisiting the natural history of chronic hepatitis B: impact of new concepts on clinical management.The natural history of chronic hepatitis B.Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.Hepatitis B virus S gene escape mutants.Broad spectrum of hepatocyte inclusions in humans, animals, and experimental models.Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA: A community-based study.Antibodies to the RNase H domain of hepatitis B virus P protein are associated with ongoing viral replication.The secretory core protein of human hepatitis B virus is expressed on the cell surface.Comparison of methods for detection of hepatitis B virus DNA.New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection.Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells.Review: Present and future directions in the treatment of chronic hepatitis B infection.Intracellular metabolism of beta-L-ddAMP-bis(tbutylSATE), a potent inhibitor of hepatitis B virus replication.Clinical profile, genotype and management updates of hepatitis B virus.Natural history of chronic hepatitis B virus infection.Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B.
P2860
Q24244433-DD9CCFBC-9203-4B52-AC27-2C7411CCF296Q33753308-51BCCA69-4C07-4797-B064-4349EA11196CQ33855246-AE60F7ED-CD1D-412E-A73A-8082B73D541CQ33894481-E9D60C85-419B-4B1A-9017-F0CD520734E6Q33933564-B6028325-BF58-4F7B-B758-6B174EB4806AQ34282823-4E9DAECB-5AB3-4FF2-8834-DFE0B91AB15CQ34350664-9352FE82-151E-423E-806A-52DB35F80453Q34408879-C5C510B1-15F1-4493-BB9F-118530458F12Q34434784-B7582D78-FFD3-45BF-86E9-F79BBA5E5086Q34568921-F1AA8EA3-F641-40E8-AFE3-EF07B4FAB303Q34585496-D28C7936-6CE1-469F-8444-84964BD503A3Q35231554-A9A11E04-C3FB-4EA1-98EE-FBAB71C9A8B2Q35596038-7CC47752-E8E7-411D-901F-0FAA0B645233Q35632910-83715597-5B16-4ED3-9D7E-5FB94B3E96A1Q35663840-AE9653AF-0265-447C-A3DF-91DA60940C9EQ35764338-D07A8BF4-112F-4765-A6FD-0D79D79938E1Q35847850-513A8252-7BEA-4378-9CD5-B5A0FD723CC7Q35938992-54E66546-09D0-4090-9427-3004BDD3C6F2Q36368397-43FA6B29-D2D9-476A-955B-1A236D29A5E9Q36627152-A4845648-D6CA-4DC0-9869-7BD64FC083E5Q36628522-44A4941E-5E79-4A88-970A-014E6EE35D21Q36632233-CBB7BC58-77EF-4634-AA28-C6D95E94966FQ36643160-C83DFD7E-A592-4405-94F5-99E06CBFC094Q36816153-7A5534F7-B932-4CBF-AAE8-D369F4FF46E0Q36980704-C75BED39-DC13-4B1C-ACAD-C47FAA4E2F59Q37388018-4561FB48-8E5A-41F1-BE8F-A2189EBDB635Q37510933-E0F9A37D-0537-4B63-98B7-15BB0586CF54Q37936822-912C2EFB-A805-4BA3-BBA1-8829B558634BQ38165139-D0B63AA8-F90F-4DE2-96C7-3EB760958111Q40079864-BB924F2F-8ED0-4815-9F16-59DC69A993CBQ40105001-D7FA67F0-3A90-41A1-8780-5759A9ADC364Q40117833-0B646438-65E0-47E1-9693-500EA6F8F661Q40179952-38CCD4F4-531C-4E48-BD39-0D8C552F4420Q40186129-C8F90489-9139-4608-BB34-5BA93A81F43DQ40341985-C91B3613-0CA1-4BE8-9E4E-CBD22A3937BDQ40866538-16210DEC-2844-40E0-B07D-2BD98B50322EQ40937828-1813ABD2-E846-491A-883F-7291E53DFD3DQ42879845-28358502-B6A8-44C4-8B39-7CB4D1102793Q45741265-261ED16C-2378-4E5E-A4B9-7328DC3AA68FQ45741649-D6D34C57-02AA-4978-8DD1-DE72522201E1
P2860
Chronic type B hepatitis and the "healthy" HBsAg carrier state.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Chronic type B hepatitis and the "healthy" HBsAg carrier state.
@en
Chronic type B hepatitis and the "healthy" HBsAg carrier state.
@nl
type
label
Chronic type B hepatitis and the "healthy" HBsAg carrier state.
@en
Chronic type B hepatitis and the "healthy" HBsAg carrier state.
@nl
prefLabel
Chronic type B hepatitis and the "healthy" HBsAg carrier state.
@en
Chronic type B hepatitis and the "healthy" HBsAg carrier state.
@nl
P2093
P2860
P356
P1433
P1476
Chronic type B hepatitis and the "healthy" HBsAg carrier state.
@en
P2093
Hoofnagle JH
Shafritz DA
P2860
P304
P356
10.1002/HEP.1840070424
P407
P577
1987-07-01T00:00:00Z